Skip to main content
Tecan Group AG logo

Tecan Group AG — Investor Relations & Filings

Ticker · TECN ISIN · CH0012100191 LEI · 529900CSN9R3BLETSL26 SW Manufacturing
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-02-09 Annual Report
Country CH Switzerland
Listing SW TECN

About Tecan Group AG

https://www.tecan.com/

Tecan Group AG is a global provider of automated laboratory instruments and solutions for the life sciences, clinical diagnostics, and applied markets. The company develops, manufactures, and distributes a wide range of products, including robotic liquid handling platforms, microplate readers, washers, and related reagents and consumables. Tecan's offerings are organized into three key segments: Life Sciences, providing automation for research; Diagnostics, offering scalable solutions with deep regulatory expertise for clinical settings; and Partnering, which delivers OEM components and services to other healthcare companies. By enhancing the precision, efficiency, and reproducibility of laboratory workflows, Tecan empowers its customers to accelerate scientific discovery and scale healthcare innovation.

Recent filings

Filing Released Lang Actions
Konzernabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Annual Report Classification · 100% confidence The document is a 'Konzernabschluss' (Consolidated Financial Statement) and 'Konzernlagebericht' (Group Management Report) for Nynomic AG for the fiscal year 2024. It contains detailed financial performance data, segment reporting, and management analysis of business operations. Since it covers the full fiscal year and provides comprehensive financial statements and analysis, it is classified as an Annual Report (10-K equivalent in the German context). FY 2024
2026-02-09 German
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
AGM Information Classification · 95% confidence The document is a short excerpt from the minutes of a general meeting (Jahreshauptversammlung) of tec5 AG. It specifically records a resolution regarding the exemption from the disclosure of the annual financial statements (Jahresabschluss) pursuant to § 264 Abs. 3 HGB for the 2024 fiscal year, along with a confirmation of a profit transfer agreement. Since this relates to the proceedings and resolutions of a general meeting, it falls under the category of AGM Information.
2026-01-21 German
Investor Presentation 2023
Investor Presentation Classification · 95% confidence The document is a corporate publication titled 'Scaling Healthcare Innovation Globally' from Tecan. It focuses on company strategy, product innovations (Veya platform, Fluent workstations), and case studies of customer collaborations. It lacks the formal financial statements, balance sheets, or income statements required for an Annual Report (10-K) or Interim Report (IR). It is not a transcript, a regulatory filing, or a specific shareholder notice. It functions as a marketing and strategic overview document, which is best categorized as an Investor Presentation (IP) as it outlines the company's value proposition, market position, and strategic growth initiatives for stakeholders. FY 2023
2025-03-07 English
Annual Report 2023
Annual Report Classification · 95% confidence The document is titled 'Annual Report' and contains a CEO letter, detailed descriptions of company business segments (Life Sciences and Partnering Business), and strategic initiatives regarding NGS and Proteomics. While it lacks the full financial tables in this specific excerpt, the content is clearly the narrative portion of an Annual Report. According to the provided definitions, this falls under the Annual Report (10-K) category. FY 2023
2024-03-07 English
Investor Presentation 2022
Investor Presentation Classification · 85% confidence The document is a thematic publication from Tecan titled 'Tecan's role in fighting cancer: from research to clinic'. It functions as a corporate narrative or 'Annual Report' supplement focusing on a specific strategic area (oncology). While it mentions 'This year's annual report from Tecan', the document itself is a descriptive, marketing-oriented overview of the company's business segments, technologies, and industry role rather than the formal financial statements or regulatory filing required for a 10-K or IR. Given the detailed presentation of company strategy, market position, and business activities, it aligns best with the 'Investor Presentation' category, as it serves to inform stakeholders about the company's operational focus. FY 2022
2023-03-09 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.